Of particular interest to our work is the study by Guo and coworkers (Guo et al., 2008) that demonstrated the anti-cancer effects of monoclonal antibodies to the phosphatases of regenerating liver (PRL) family of intracellular phosphatases. This evidence concerns the gene PRL and cancer.